↓ Skip to main content

The Brazilian private pharmaceutical market after the first ten years of the generics law

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, August 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)

Mentioned by

twitter
5 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Brazilian private pharmaceutical market after the first ten years of the generics law
Published in
Journal of Pharmaceutical Policy and Practice, August 2019
DOI 10.1186/s40545-019-0179-9
Pubmed ID
Authors

Andréa Dâmaso Bertoldi, Anita K. Wagner, Isabel Cristina Martins Emmerick, Luisa Arueira Chaves, Peter Stephens, Dennis Ross-Degnan

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 19%
Researcher 7 19%
Other 3 8%
Student > Ph. D. Student 3 8%
Student > Bachelor 3 8%
Other 3 8%
Unknown 10 28%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 5 14%
Medicine and Dentistry 4 11%
Economics, Econometrics and Finance 4 11%
Business, Management and Accounting 3 8%
Biochemistry, Genetics and Molecular Biology 3 8%
Other 5 14%
Unknown 12 33%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 June 2020.
All research outputs
#5,434,491
of 18,009,382 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#124
of 304 outputs
Outputs of similar age
#99,686
of 270,763 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#1
of 1 outputs
Altmetric has tracked 18,009,382 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 304 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 270,763 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them